News

COPD Patients with Non-Tuberculous Mycobacterial Pulmonary Disease Face Higher Mortality, Study Shows

Patients with chronic obstructive pulmonary disease (COPD) who also have non-tuberculous mycobacterial pulmonary disease (NTM-PD) are more likely to be hospitalized and die, according to a German study that urges improved care for this particular disease. The study,“Burden of non-tuberculous mycobacterial pulmonary disease in Germany,” appeared in the European…

Ventec’s VOCSN System, a 5-in-1 Portable Respiratory Device, Coming into Use

Ventec Life Systems announced that the U.S. Food and Drug Administration (FDA) has given 510(k) clearance to the company’s VOCSN life support device, which combines five respiratory therapies into one portable unit. VOCSN incorporates a critical care ventilator, a 6 l/min portable oxygen concentrator, a touch-button cough assist, a hospital-grade suction system, and…

Utibron Neohaler Inhalant Dispenser Now Available in US for COPD

U.S. pharmacies have begun carrying the Utibron Neohaler treatment-dispensing device as a long-term maintenance treatment for airflow obstruction in chronic obstructive pulmonary disease (COPD), Sunovion Pharmaceuticals announced. The powder that the device dispenses, which is a combination of  indacaterol and glycopyrrolate, is aimed at preventing bronchospasms in people with COPD.

Stem Cell Therapy Improves Lung Inflammation, Tissue Damage in Mice

Stem cell therapy reduced lung inflammation and improved lung damage repair in a mouse model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The findings were presented at the Lung Science Conference recently in Estoril, Portugal. Mesenchymal stem cell (MSC) therapy uses stem cells (multipotent cells that can differentiate into a variety…